跳至主要内容
临床试验/ACTRN12621001415897
ACTRN12621001415897尚未招募未知

The effects of Gender Affirming hormone therapy on skeletal Muscle training and Epigenetics in transgender individuals: The GAME Study

Victoria University0 个研究点目标入组 160 人开始时间: 2021年10月20日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
160

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • For participants commencing gender affirming hormone therapy:
  • Adults aged 18 years and over.
  • Willingness to consent and comply with study requirements
  • Diagnosed with gender dysphoria who are about to commence gender affirming hormone therapy
  • For matched cisgender participants:
  • Adults aged 18 years and over.
  • Willingness to consent and comply with study requirements
  • Age-matched to participating individual about to commence gender affirming hormone therapy

排除标准

  • Prior use of gender affirming hormone therapy.
  • Prior hypogonadism including previous oophorectomy or orchidectomy.
  • Past medical history of cardiovascular conditions, dizziness or fainting during exertion, significant chronic or recurrent respiratory condition, significant neuromuscular, major musculoskeletal problems interfering with ability to cycle, uncontrolled endocrine and metabolic disorders or diabetes requiring insulin and other therapies, infectious blood borne disease, disorders or use of medications that will affect blood clotting and allergies to anaesthetic.
  • Active cigarette use.
  • Language difficulties.

研究者

相似试验